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Protein foldingRussell bodies are intracellular aggregates of immunoglobulins. Although the mechanism of Russell body bio-
genesis has been extensively studied by using truncated mutant heavy chains, the importance of the variable
domain sequences in this process and in immunoglobulin biosynthesis remains largely unknown. Using a
panel of structurally and functionally normal human immunoglobulin Gs, we show that individual immuno-
globulin G clones possess distinctive Russell body inducing propensities that can surface differently under
normal and abnormal cellular conditions. Russell body inducing predisposition unique to each immunoglobulin
G clone was corroborated by the intrinsic physicochemical properties encoded in the heavy chain variable do-
main/light chain variable domain sequence combinations that deﬁne each immunoglobulin G clone. While the
sequence based intrinsic factors predispose certain immunoglobulin G clones to bemore prone to induce Russell
bodies, extrinsic factors such as stressful cell culture conditions also play roles in unmasking Russell body pro-
pensity from immunoglobulin G clones that are normally refractory to developing Russell bodies. By taking ad-
vantage of heterologous expression systems, we dissected the roles of individual subunit chains in Russell body
formation and examined the effect of non-cognate subunit chain pair co-expression onRussell body forming pro-
pensity. The results suggest that the properties embedded in the variable domain of individual light chain clones
and their compatibility with the partnering heavy chain variable domain sequences underscore the efﬁciency of
immunoglobulin G biosynthesis, the threshold for Russell body induction, and the level of immunoglobulin G se-
cretion.Wepropose that an interplay between theuniqueproperties encoded in variable domain sequences and the
state of protein homeostasis determines whether an immunoglobulin G expressing cell will develop the Russell
body phenotype in a dynamic cellular setting.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Russell bodies (RBs)wereﬁrst described as electron-dense bodies in
the cytoplasm of myeloma cells [1] and later recognized as intracellular
inclusions of aggregated immunoglobulins (Igs) enclosed in dilated en-
doplasmic reticulum (ER) [2]. This cytoplasmic structure was named
afterWilliamRussell, a physicianwho ﬁrst interpreted it as intracellular
fungi that cause cancer [3] although scientiﬁc evidence did not accrue to
support his view. Plasma cells that house RBs are known as Mott cells
and are abundantly found in lymphoid organs of autoimmune mice
[4,5] as well as in various pathological settings in humans [6,7]. The
RB biogenesis has beenmost extensively characterized by using various
subclasses of mouse mutant heavy chains (HC) lacking CH1, the ﬁrstdoplasmic reticulum; GAPDH,
chain; HEK, human embryonic
, light chain; RB, Russell body;
domain
est, Seattle, WA 98119, USA.
.
rights reserved.constant domain [8–11]. This characteristic CH1 truncation appears to
ensue somatically via errors in class switching [12] and to circumvent
the toxicity of normal full-length HC expression in the absence of light
chain (LC) expressions [13]. Because of their ability to induce RB forma-
tion, these truncated HC mutants have been widely employed as sys-
tems of choice to study RB biogenesis. However, the constant domain
deletion itself was found not to be required to induce RB formation as
shown in some IgM Mott hybridomas where the expression of intact
μ-HC was detectable [14–16]. In a more recent study, Corcos et al. [17]
showed that such truncated HC was not sufﬁcient to induce RB forma-
tion either. Namely, by comparing the RB forming frequency of
CD138+ plasma cells derived from knock-in animals (μNR) expressing
truncated IgM (lacking CH1–2 domains) [18] and from μNRL−/− mice
[19] (generated by crossing μNR mice and LC-deﬁcient L−/− mice
[20]), Corcos et al. demonstrated that the truncated μ-HC forms RBs fre-
quently only when the LC was absent, whereas RB induction was
prevented when the LC was present. Although the truncated μ-HCs
and the LCs do not covalently assemble due to the lack of CH1 domain,
the results highlighted important protective roles of LCs in preventing
truncated HCs from aggregating into RBs during IgM subunit chain bio-
synthesis in the ER lumen.
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and degradation has been proposed to play important roles in RB bio-
genesis [2,10], but the prevalence of RB formation among structurally
normal, assembly-competent human IgGs, as well as the normal full-
length subunit chains, has not been fully characterized. Whether
structurally normal individual IgG clones are equally prone to, or re-
sistant to, induce RB formation under normal and aberrant cellular
conditions, and what intrinsic and extrinsic factors contribute to the
RB inducing propensities of each IgG clone are not well studied either.
Furthermore, whether there is any difference in the contribution of
HC or LC subunit chain toward RB formation is largely unknown. De-
spite the numerous clinical case reports on RB development in pa-
tients of B cell lymphoproliferative disorders and B cell malignancy,
the mechanisms of RB induction in vivo by normal full-length IgGs
and their pathophysiological roles have been unclear.
To address currently unknown aspects of RB biogenesis, we took full
advantage of robust recombinant IgG expression systems that allow us
to evaluate RB formation independent of the CH1 domain deletions that
are found in homologous experimental systems. We employed a panel
of functionally and structurally normal fully-human IgGs to investigate
the RB inducing propensities of individual Ig clones in heterologous sys-
tems. Ourwork showed that normal IgGswithout discernible structural
defects can induce RB formation under various cellular conditions. The
thresholds for RB induction varied signiﬁcantly from clone to clone.
Some IgG clones readily induced RBs at high frequency under normal
cell growth conditions, whereas other IgG clones were more refractory
to develop RBs even under the conditions of ER-to-Golgi transport block
or heat shock. The RB-prone IgGs secreted rather poorly and were in-
clined to deteriorate cell health, while the RB-resistant IgGs were typi-
cally secreted at high titers and allowed the host cells to maintain
high viability for a prolonged period.When the protein folding environ-
ment in the ER was disrupted by thapsigargin, even the high secreting
IgG clones came to induce RB formation in host cells. By expressing in-
dividual subunit chains separately, we demonstrated that LCs from RB-
resistant IgG clones had a high competency to assist IgG assembly and
to facilitate robust IgG secretion. By co-expressing a battery of non-
cognate HC/LC pairs, we found that the LC's high competence alone
was not sufﬁcient to ensure high secretion level. Conversely, however,
a LC's low competence was sufﬁcient to promote RB formation and to
dampen secretion levels signiﬁcantly. A cognate pair of VH/VL did not
always provide the maximum biosynthetic efﬁciency although the
same pair may impart desired antigen speciﬁcity and biological func-
tions. This observation inadvertently illustrated the limitation of a
scaffold-based protein design that accommodates diverse sequence
composition in one structural conﬁguration so that the efﬁciency of
subunit assembly reactions would vary inevitably from clone to clone.
New insights obtained from our study not only shed light on physio-
logicalmechanisms that lead to RB formation in vivo, but also help us un-
derstand the roles of VH/VL primary sequences in determining the
efﬁciency of IgG biosynthesis and the contribution of secretory cargo's
physicochemical properties to the severity of ER storage disease pheno-
types. Potential impact of the current study on the biotechnology of ther-
apeutic antibody discovery and recombinant IgG expression is discussed.
2. Materials and methods
2.1. Reagents
All the chemical and biological reagents were obtained from Sigma-
Aldrich unless speciﬁcally mentioned.
2.2. Detection antibodies
Rabbit anti-calnexinwas from Sigma-Aldrich. Goat anti-murine IL-31
was from R&D Systems. Mouse anti-GAPDH (clone 6C5) was from
Chemicon. Mouse anti-CD147, mouse anti-calreticulin, mouse anti-BiP,mouse anti-PDI, and mouse anti-GM130 were from BD Transduction
Laboratories. Mouse Anti-ERp57 (MaP.ERp57), mouse anti-Ero1α
(D-7), mouse anti-calnexin (E-10), and goat anti-XPB1 (R-14) were
from Santa Cruz Biotechnology. Mouse anti-CHOP (clone L63F7)
was from Cell Signaling Technology. Afﬁnity puriﬁed Rabbit anti-
human IgG (HC+LC) was from Jackson ImmunoResearch Laborato-
ries. FITC- or Texas Red-conjugated goat anti-human gamma chain,
kappa chain, and lambda chain were from Southern Biotech.
2.3. Recombinant antibody expression and IgG quantiﬁcation
Detailed procedures for recombinant antibody cloning and ex-
pression were described previously [21,22]. In brief, after extracting
total RNAs from individual clonal hybridoma lines, the cDNAs for
heavy chain (HC) or light chain (LC) variable domains were ampli-
ﬁed by RT-PCR using multiplexed oligo primer sets that encompass
the N-terminal sequences and the beginning of constant domain se-
quences. The design of PCR oligo sets was based on all known
germline sequences. Ampliﬁed PCR products were puriﬁed from aga-
rose gels after electrophoresis and fully sequenced. Ampliﬁed vari-
able domain sequences were joined to cognate constant domain
coding sequences by widely used PCR-based techniques without in-
troducing irrelevant nucleotide sequences in order to reconstitute
the entire open reading frames for HC and LC. The coding sequences
for the individual HC or LC were subcloned into pTT5 expression vec-
tor for transient transfection in mammalian cell hosts. The ﬁnalized
expression constructs were transiently transfected to HEK 293-
EBNA1 (clone 6E) or CHO-EBNA1 (clone 3E7) at the HC-to-LC plas-
mid DNA ratio of one-to-one (normalized by weight). The expres-
sion vector and the host cell lines were obtained from National
Research Council of Canada and were used according to the detailed
guideline published previously [23]. Cells were cultured in Freestyle
293 medium or Freestyle CHO medium (both from Invitrogen) in
suspension format using disposable plastic shaker ﬂasks (Corning)
placed on Innova 2100 shaker platforms (New Brunswick Scientiﬁc)
rotating at 150 rpm in humidiﬁed incubators adjusted to 37 °C, 5%
CO2. On day-1 post transfection, the cells were fed with yeastolate
supplement (BD Biosciences) to a ﬁnal 0.5% (w/v) from a 20% stock
solution. The cell culture media were harvested at day-6 post trans-
fection for secretion titer determination, protein puriﬁcation, and
other analytical purposes. The cell viability and cell density were
monitored by using Vi-CELL XR (Beckman Coulter) during produc-
tion cell culture and at the time of harvest. The human IgG concen-
tration in the harvested culture media was quantitated using Octet
RED96 (ForteBio) equipped with Protein A biosensors according to
the manufacturer's instructions.
2.4. Western blotting
SDS-PAGEwas performed using Invitrogen's NuPAGE 4–12% Bis-Tris
gradient gel and a compatible buffer system. Both the cell culturemedia
and the cell pellets were heat treated at 95 °C for 5 min in NuPAGE LDS
sample buffer (Invitrogen) after adjusting to the designated ﬁnal work-
ing concentration. Reducing conditions contained 5% (v/v) of beta-
mercaptoethanol, whereas non-reducing conditions contained 2 mM
N-ethylmaleimide as an alkylating agent in addition to the NuPAGE
LDS sample buffer. Resolved proteinswere electrotransferred to a nitro-
cellulosemembrane, blockedwithOdyssey blocking buffer (LI-COR Bio-
sciences), and probed with the designated primary antibodies. After
washes in PBS containing 0.05% (v/v) Tween-20, the nitrocellulose
membranes were probed with AlexaFluor 680-conjugated secondary
antibodies (Invitrogen), followed by washing steps. The membranes
were scanned using individually determined optimal scanning settings
that allowed maximum dynamic range without saturating speciﬁc sig-
nals. The images were acquired, and quantitated when necessary, by
using the Odyssey infrared imaging system (LI-COR Biosciences).
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Suspension cultured HEK 293 or CHO cells were withdrawn from
shaker ﬂasks on day-2 or day-5 post transfection and seeded onto poly-
lysine coated glass coverslips using a fresh, yeastolate-supplemented
cell culture medium in the presence or absence of 15 μg/ml of Brefeldin
A, 40 °C heat shock, or 1 μM thapsigargin. After 24 h of static culture
under the designated conditions, cells were ﬁxed in 0.1 M sodium phos-
phate, pH 7.2, containing 4% (w/v) paraformaldehyde for 30 min at room
temperature. After washing steps in PBS containing 0.1 M glycine, the
ﬁxed cells were incubated with permeabilization buffer (PBS containing
0.4% (w/v) saponin, 1% (w/v) BSA, 5% (w/v) ﬁsh gelatin) for 15 min,
followed by incubationwith primary antibody in permeabilization buffer
for 60 min. After washes in permeabilization buffer, the cells were incu-
bated with AlexaFluor 488- or 594-conjugated secondary antibodies
(Invitrogen) in permeabilization buffer for 60 min. Coverslips were
mounted onto slide glass usingVectaShield (Vector Labs) and cured over-
night at 4 °C. The slideswere analyzed using aNikon Eclipse 80i or Eclipse
Ti-E microscope using a 100×, 60×, or 40× CFI Plan Apocromat oil objec-
tive lens and Chroma FITC-HYQ or Texas Red-HYQ ﬁlter. Images were ac-
quired using a Cool SNAP HQ2 CCD camera (Photometrics) and Nikon
Elements imaging software.
2.6. Flow cytometry
Suspension cultured HEK 293 cells were harvested from shaker ﬂasks
on day-2 post transfection by low speed centrifugation (1000 g, 5 min).
Cells were ﬁxed using the same ﬁxation buffer used in microscopy for
30 min at room temperature. After washing steps in PBS containing
0.1 M glycine by repeating low speed centrifugation procedures, the
ﬁxed cells were incubatedwith permeabilization buffer (same asmicros-
copy) for 15 min, washed as before, then stained with R-Phycoerythrin-
or FITC-conjugated primary antibodies speciﬁc to gamma, kappa, or
lambda chain (SouthernBiotech) in permeabilization buffer for 60 min.
Staining condition was 2 μg of antibody per 106 cells per 200 μl. The
stained cells were washed with permeabilization buffer as before, and
resuspended in PBS containing 0.5% (w/v) BSA before analysis. Flow cy-
tometry datawere acquired on aBDFACSCaliburﬂowcytometer, utilizing
BD CellQuest Pro software (both from BD Bioscience).
2.7. Intracellular IgG solubility assay
On day-2 post transfection, HEK 293 cells were collected by 5 min
centrifugation at 1000 g. To obtain total cell lysate, cell pellets were
directly incubated on ice for 15 min in a lysis buffer (20 mM Hepes,
pH 7.2, 150 mM KCl, 2 mM EDTA, 1% (v/v) Triton X-100) containing
Complete™ protease inhibitor cocktails (Roche) while being thor-
oughly mixed by pipetting. The total cell lysates were subjected to
100,000 g ultracentrifugation for 60 min to separate the soluble frac-
tion from insoluble particulate components. The insoluble compo-
nents were re-suspended in the lysis buffer and were adjusted to
the original sample volume. A normalized equal volume of total ly-
sate, soluble fraction, or reconstituted insoluble component was
heat treated at 95 °C for 5 min in a freshly prepared reducing LDS
NuPAGE sample buffer. Prepared samples were analyzed by Western
blotting using the designated primary antibodies.
3. Results
3.1. The difference in IgG secretion level is rooted in the variable domain
sequences
To examine Russell body (RB) inducing propensities of structural-
ly normal full-length IgGs, we took advantage of a pre-existing panel
of fully human IgG clones available to us. Our ﬁrst panel of monoclo-
nal antibodies is three IgG1 clones (A, B, and C) and the second panelis a set of three IgG2 clones (1, 2, and 3). Monoclonal antibodies in each
panel were raised against two unrelated human proteins (e.g., a type II
membrane-anchored protein and a cytokine) and selected based on
their designated antigen binding ability by various assays after puriﬁca-
tion to homogeneity (data not shown). All six IgG clones were derived
from XenoMouse® [24], a transgenic animal that harbors the human
immunoglobulin (Ig) repertoire. When expressed using suspension
adapted HEK 293 cells in a 6-day batch cell culture process following
transient transfection, there were as much as two orders of magnitude
difference in apparent secretion titer among the model IgG clones. In
theﬁrst panel, cloneA consistently yielded 100–300 mg/l of IgG,where-
as clones B and C were secreted at much lower levels, 10–30 and
1–3 mg/l, respectively (Fig. 1A, B). The three clones in the second
panel showed a similar range of differences inwhich the titers of clones
1, 2, and 3 were ~100, ~1, and ~10 mg/l, respectively (Suppl. 1A). In
spite of the secretory titer variations, we did not detect marked differ-
ences in steady state intracellular protein levels of heavy chain (HC)
and light chain (LC) under reducing conditions (Fig. 1C, left) or the
ratio of various folding intermediates under non-reducing conditions
(Fig. 1C, right). The apparent gel mobility differences among the LCs
can be attributable to the isoelectric point difference of the constant do-
main region between the lambda LCs (pH 6.91) for clone A and kappa
LCs (pH 5.58) for clones B and C, despite the constant domain being
composed of 106 amino acid residues in both isotypes. Flow cytometric
analysis on the transfected cell population revealed that the percentage
of cells that expressed both subunit chains was similar regardless of
which IgG clone was expressed; it consistently ranged from 45% to
55% (Fig. 1D). Therefore, neither the steady state intracellular protein
level nor the apparent transfection efﬁciency was the direct cause for
the observed secretion titer differences.
The antigen binding ability of individual secreted IgGs, which is
how the individual clones were selected in the ﬁrst place, implicated
that there were no intrinsic gross structural defects that hampered
the correct folding of the Fab domain regions. The thermo-melting
proﬁles of individual IgG clones by differential scanning calorimetry
(DSC) showed expected signature differences in the DSC proﬁle
unique to individual IgG clones, but there was no notable structural
instability unless a set of mutations was introduced to the Fc region
(Suppl. 2). Similar conclusions were drawn for the IgG clones in the
second panel (data not shown).
We examined the allotypic variationswithin the IgG1 Fc domain, dif-
ferent gamma HC subtypes (e.g., G1 vs. G2), N-linked glycan site muta-
tion (e.g., N297A), and various exogenous signal sequences, but none
of the primary sequence alterations outside of the variable domain pro-
foundly inﬂuenced the secretion level (data not shown). By rational
elimination, it was most likely the sequences of the variable domains
(VH and VL) that played major roles in inﬂuencing secretion titers in
overexpression settings (see below formore evidence). These initial re-
sults helped us articulate our guiding hypothesis that the unique VH/VL
sequence composition of the individual IgG clone plays important roles
not only in generating unique antigen binding speciﬁcity, but also in
giving rise to distinctive physicochemical properties that directly mod-
ulate the biosynthetic processes of individual IgG clones.
3.2. Poorly secreting recombinant IgG clones become largely insoluble
during biosynthesis
The solubility of intracellular protein pools using detergent
extracted cell lysates uncovered important differences between high-
ly and poorly secreting clones. On day-2 post transfection, cells were
detergent lysed under non-denaturing conditions and the total cell
extracts were subjected to ultracentrifugation to obtain soluble and
insoluble fractions. When each fraction was analyzed by Western
blotting, the intracellular pool of high-secreting clone A remained
predominantly soluble (Fig. 2A, left panel), whereas more than 50%
of the poorly secreting clones partitioned to the particulate fractions,
Fig. 1. Secretion titer differences among the three model IgG clones. (A) On day-6 post transfection, HEK 293 cell culture media were harvested to perform Western blotting anal-
ysis. The secreted human IgG in the transfected cell culture media was resolved by SDS-PAGE under reducing conditions (left panel) or non-reducing conditions (right panel) and
probed using rabbit anti-human IgG (HC+LC) polysera and Alexa 680 conjugated anti-rabbit IgG secondary antibody. A liquid volume corresponding to 5 μl of harvested cell cul-
ture medium was analyzed in each lane. The protein bands of heavy chain (HC) and light chain (LC) are marked by arrowheads in the left panel. Likewise, the whole IgG is marked
by an arrowhead in the right panel. Molecular size standard is shown on the left side of the gel. (B) The secretion titers for clones A, B, and C were determined using cell culture
media harvested on day-6 post transfection. The average of twelve transfection experiments is shown in this bar graph. Error bar denotes standard deviation. (C) Transfected
cells were harvested by 1000 g centrifugation on day-6 post transfection. Cell pellets were directly lysed in SDS sample buffer and heat treated. The intracellular pools of human
IgG were resolved under reducing conditions (left) or non-reducing conditions (right). The protein bands corresponding to each subunit chain is labeled as HC or LC for the reducing
conditions. Bottom panel shows the Western blotting of the same cell lysate samples probed by anti-GAPDH to demonstrate loading equivalency. (D) 2D density plot data of ﬂow
cytometric analysis on transfected cell population. On day-2 post transfection, transfected cell population was harvested from shaker ﬂasks, ﬁxed, permeabilized, and immuno-
stained with the designated antibodies. Fluorescent signals generated by the anti-gamma chain staining are shown on the horizontal axis and those of anti-kappa or anti-
gamma chain staining are shown on the vertical axis. The constructs used to transfect the HEK 293 cells are shown at the top of each 2D plot. The percentage of cells that falls
into each quadrant is shown in the 2D plot.
1646 J. Stoops et al. / Biochimica et Biophysica Acta 1823 (2012) 1643–1657illustrating the formation of insoluble aggregates inside the express-
ing cells (Fig. 2A, middle and right panels). The detection of two ER
resident proteins in the soluble fraction implicates the thoroughness
of membrane extraction steps (Fig. 2A, second and third rows). For
confounding technical reasons, the ultracentrifugation step caused in-
soluble proteins to become refractory to SDS and 95 °C heat treat-
ment and we could not recover all the proteins from the particulate
fraction for Western blotting analysis. Therefore, the actual percent-
age of clones B and C that ended up in the insoluble fraction could
be much higher than shown in the blot.
The dynamics of the intracellular protein pools revealed another
key difference. We measured how fast the speciﬁc proteins of interest
were emptied from the cells either by secretion or by degradation. To
this end, we blocked de novo protein synthesis by treating the cells
with 300 μg/ml cycloheximide (CHX) and monitored the amount of
intracellular HC and LC by Western blotting for the next 12 h. We
resorted to this method instead of a classic pulse-chase metabolic la-
beling technique to avoid the complications of having to discrimi-
nate radio-labeled intracellular IgGs that become part of theinsoluble aggregates from that which remain soluble. During the
12 h CHX treatment, cell viability was minimally impacted but cell
doubling was inhibited (see legend, Fig. 2B and Suppl. 1C). In order
to normalize sample analysis, each lane was loaded with whole cell
lysates prepared from 12,000–12,500 cells at each time point. Be-
cause non-secretory cellular protein may differentially turnover
according to their own programmed kinetics under a translation
block, we chose this mode of sample normalization instead of pro-
tein concentrations. Speciﬁc signals of individual IgG subunit chains
or reference proteins were probed (Fig. 2B) and quantiﬁed by infra-
red image scanning systems (Fig. 2C). Both HC and LC of clone A
showed similar kinetics of signal decrease which took about 9 h be-
fore the speciﬁc intracellular protein level became 50% of the original
(Fig. 2C, left). A reference protein, recombinant murine cytokine IL-
31, showed a much faster kinetics of disappearance (50% decrease
in ~1 h) (Fig. 2C, left). In contrast, the signals of poorly secreting
clones B and C did not decrease measurably during the 12 h testing
period (Fig. 2C, middle and right). To monitor general cellular pro-
tein turnover during the testing period and to gauge equivalent
Fig. 2. Intracellular protein pools show distinct characteristics between high and low secreting IgG clones. (A) Using transfected HEK 293 cells, the solubility of intracellular protein
pools was determined on day-2 post transfection. Whole cell extracts were prepared under non-denaturing conditions and subjected to ultracentrifugation. Total, soluble, and par-
ticulate fractions were resolved in SDS-PAGE under reducing conditions. Nitrocellulose membranes were probed with rabbit anti-human IgG (HC+LC) (top panel), rabbit anti-
calnexin (middle), or mouse anti-calreticulin (bottom). (B) HEK 293 cells were transfected with expression vectors encoding model human IgG clones or murine IL-31. At 48 h
post transfection, HEK 293 cells in suspension culture were treated with 300 μg/ml cycloheximide (CHX) for up to 12 h while monitoring the intracellular level of speciﬁc proteins
by Western blotting. SDS-PAGE was run under reducing conditions. (Left three panels) Clones A, B, and C were probed with rabbit anti-human IgG (HC+LC). The right panel was
probed with goat anti-murine IL-31. Each lane was loaded with whole cell lysates prepared from 12,000–12,500 cells at each time point. Cell viabilities for clones A, B, and C after
12 h CHX treatment were 97.4%, 96.4%, and 95.2%, respectively. Viable cell density increases during this period were 9.9%, 7.7%, and 6.5%, respectively. For mu IL-31 transfected cells,
cell viability after 12 h CHX treatment was 94.1%. Viable cell density increase during this period was 11.4%. (C) TheWestern blot signals for clones A, B, C, and murine IL-31 as well as
three cellular proteins were digitally quantitated using LiCor infrared imaging software. Integrated signal intensity of speciﬁc protein band(s) was determined and plotted in a per-
centage scale. Vertical axis shows the relative signal strengths. Horizontal axis shows the duration of CHX treatment.
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proteins GAPDH, calnexin, and BiP during the 12 h CHX treatment.
For all three cellular proteins, we did not observe detectable protein
reduction during the testing period (Fig. 2B bottom forWestern blot;
Fig. 2C for quantiﬁcation); perhaps indicating that they were not
subjected to a rapid turnover. The results additionally implicated
that there were no abrupt necrotic events that might cause a sudden
loss of cytosolic protein content such as GAPDH during this period.
Despite clones B and C becoming largely insoluble during biosynthe-
sis in the ER, we did not detect marked turnover differences of two
classical ER resident proteins during the 12 h CHX treatment regard-
less of which IgG clones were expressed. Likewise, when the three
clones in the second panel were tested, we obtained similar patterns
of speciﬁc protein signal reduction for highly secreting clone 1which
decreased to 50% of the original level in roughly 8 h, whereas poorly
secreting clones 2 and 3 showed less than 10% decrease during the
12 h period (Suppl. 1C). Murine IL-31 again disappeared by 50% in
about 1 h. Supplementation of 20 μg/ml puromycin (which inhibits
ribosomal function by a distinct mechanism) on top of the 300 μg/
ml CHX did not alter the kinetics of speciﬁc signal decrease, thereby
indicating that the translation inhibition was thorough in our exper-
iments. In summary, the intracellular pools of poorly secreting IgG
clones were recalcitrant to degradation and simultaneously notamenable to secretion. In other words, they were most likely termi-
nally misfolded within the secretory pathway organelles.
3.3. Russell body formation is induced at high frequency in cells expressing
poorly secreting IgG clones
Intracellular protein quality and dynamics were markedly differ-
ent between the high-secreting and the low-secreting IgG clones. Ad-
ditional clues that distinguish the cells expressing high-secreting
from low-secreting IgG clones were provided when we monitored
the health of transfected cells during our 6-day IgG production pro-
cess. The cells expressing poorly secreting IgG clones were more apo-
ptotic and deteriorated faster during the second half of our 6-day
process (Suppl. 3). To investigate further on the cause of poor secre-
tion in some IgG clones, we analyzed the steady state subcellular lo-
calization of individual IgG clones by ﬂuorescent imaging. This study
provided important clues to the underlying mechanisms of poor se-
cretion and to the deterioration of cell health in low-secreting IgG ex-
pressing cells. To ensure that we performed cellular imaging during
the time window when the cells were abundantly synthesizing re-
combinant IgGs while the health of transfected cells was not com-
promised, we seeded the transfected cells on glass coverslips on
day-2 and carried out the imaging on day-3 post-transfection. After
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ﬁbroblast-like morphology, and the cargo IgG ﬁlled the calnexin-
positive reticular organelles (Fig. 3A, top row). In contrast, although
the cells expressing clone B or C stably adhered to the coverslips,
the cells showed round morphology and housed prominent IgG-
positive aggregates known as Russell bodies (RBs) at high frequency
(Fig. 3A, second and third rows). The occurrences of RB formation are
as follows: clone A, 1.1% (RB positive cells/transfected cells=1/95);
clone B, 55.6% (60/108); and clone C, 72.9% (210/288). In this work,
we primarily relied on an anti-IgG (gamma, kappa, and lambda sub-
units) antibody staining to visualize RBs by immunoﬂuorescent micros-
copy. Although 3D deconvolution imaging revealed that different focal
planes can give different RB shapes and sizes in a given cell (data not
shown), the RB was readily discernible when the cells housed RBs. Be-
cause non-transfected cells in the same ﬁeld showed ﬁbroblast-like
morphology, the cell roundingwasnot caused by general cell culture de-
terioration, but rather it is an apparent cytopathic effect of RB formation
that might have been caused by the hindrance of efﬁcient mem-
brane trafﬁcking in the secretory pathway. As reported previously
[10], calnexin (amembrane-anchored ER resident protein)was associat-
ed with the RBs, implicating that the ER membrane was part of the aber-
rant structures (Fig. 3A, bottom row, arrow). In agreement with the
pronounced cell health divergence between high- and low-secreting IgG
expressing cells at day-5 or day-6 (Suppl. 3), when the cells were imaged
on day-6, we saw marked morphological differences depending on
whether the cells express high- or low-secreting IgG clones. Whereas
the cells expressing IgG clone A maintained ﬁbroblast morphology and
continued to populate the secretory organelles with cargo IgG (Fig. 3B,
top row), the cells expressing cloneBor Chad apparently lost intracellular
integrity as evidenced by the loss of cis-Golgi marker staining (3B, middle
and bottom rows). Similarly, when the three clones of the second panel
were examined on day-3, the cells expressing high-secreting clone 1
maintained ﬁbroblast morphology without developing RBs (Suppl. 4A,
top row),whereas the cells expressing clone 2 or 3 rounded up anddevel-
oped readily discernible RBs at high frequency (Suppl. 4A, middle and
bottom rows).
The RB induction by the model IgG clones was not a peculiar oc-
currence in HEK 293 cells. When a similar experiment was repeated
in CHO cells using the three IgG clones in the ﬁrst panel, the high se-
creting clone A did not induce RBs, whereas the expression of clones B
and C induced RB formation (Suppl. 5). Interestingly, the gross mor-
phology of RBs was markedly different from what we observed in
HEK 293 cells. The RBs were mostly perinuclear in this cell type
(Suppl. 5, arrows) instead of being juxtanuclear globular structures.
The difference in apparent RB morphology and RB inducing frequency
between the two cell types can be attributable to the inherent cellular
capacity differences in protein synthesis, degradation, or ER-to-Golgi
trafﬁcking as suggested previously [8]. In summary, intrinsic proper-
ties of individual IgG appear to play roles in determining RB forming
propensity, and the cellular context, in return, can inﬂuence the se-
verity of RB inducing phenotypes.
3.4. The components of ER protein foldingmachinery are induced at similar
kinetics in the IgG expressing cells regardless of the RB-forming propensity
differences
Insufﬁcient protein folding capacity is frequently attributed to the
generation of aggregated protein species [25–27]. To test if there was
any kinetic or magnitude difference in the induction proﬁle of protein
folding machinery between the cells expressing highly and poorly se-
creting IgG clones, we monitored the levels of classic ER resident pro-
teins during the 6-day period after transfection. Possibly because the
cells had been maintained in log growth phase for a prolonged period,
our HEK 293 cells had low ER resident protein contents prior to trans-
fection (Fig. 4, day-0). However, along with the induction of ~50 kDa
XBP1(S) protein, all the examined ER-resident proteins were acutelyelevated after transfection (Fig. 4). For example, for the clone A ex-
pressing cell population, the day-0 to day-4 fold increases in signals
for calnexin, Ero1α, BiP, and GAPDH were 4, 13, 26, and 1, respective-
ly. Importantly, regardless of the RB forming propensity or the secre-
tion levels, the induction proﬁles of the ER resident proteins were
similar. For the IgG clones with “favorable” properties, such as clone
A, the acute cellular response was apparently sufﬁcient to cope well
with the abrupt increase in folding demand despite the initial low fold-
ing capacity, leading to the high secretion titers. In contrast, for the
clones with potentially “unfavorable” attributes such as clone B or C,
the similar kinetics and magnitude of cellular response were not effec-
tive enough to support an efﬁcient biosynthetic process; hence, the
IgGs terminally misfolded into insoluble aggregates, formed RBs, and
resulted in low secretion titers. Our results illustrate that the cargo's in-
trinsic unique properties, attributes, or characteristics play signiﬁcant
roles in determining the efﬁciency of IgG biosynthesis when the cellular
background is identical.
Because there was a notable difference in cell health during the sec-
ondhalf of the 6-day cell culture process (Suppl. 3), we decided tomon-
itor the ER stress marker CHOP [28] to see if the CHOP levels correlate
with cell health deterioration.We found that CHOPwas induced regard-
less of whether the cells expressed high- or low-secreting IgG clones.
However, the kinetics and the magnitude of induction appeared to be
different between the cells expressing high-secreting clone A and
low-secreting RB-prone clones B and C (Fig. 4, bottom panel). The re-
sults were consistent with the observed cell viability differences be-
tween the cells expressing high- and low-secreting IgG clones.3.5. Disruption of ER functions by thapsigargin leads to marked induction
of RB formation in cells expressing high-secreting IgG clones
When cultured under normal growth conditions, the cells ex-
pressing highly secreting clones such as clone A and clone 1 did not
induce detectable RB formation. In contrast, the cells expressing poor-
ly secreting clones all formed RBs at high prevalence under the same
settings. To interrogate the RB forming propensities of robustly se-
creting IgG clones, we cultured the cells under adverse conditions
that disturb cellular protein homeostasis. Namely, we tested Brefeldin
A (BFA) to block ER-to-Golgi transport, 40 °C heat shock to disturb
global cellular functions, and thapsigargin to deplete ER luminal calci-
um to perturb ER resident protein functions. In each case, transfected
cells were exposed to the designated stressful conditions for 24 h be-
tween day-2 and day-3 post transfection. A 24 h BFA treatment at
15 μg/ml did not compromise HEK 293 cell viability signiﬁcantly
(see legend, Fig. 5 and Suppl. 1), but the secretion of IgG was blocked
as expected (Fig. 5A and Suppl. 1B). The observation that IgG release
was inhibited by BFA treatment is most consistent with the IgG being
secreted via an ER/Golgi-dependent mechanism, as opposed to a ne-
crotic release or some other pathways. Regardless of whether the
cells were transfected or not, cell morphology rounded up after the
BFA treatment (as expected from compromised membrane trafﬁcking
in the secretory pathway). Despite the secretion block, the cells ex-
pressing IgG clone A did not develop readily discernible RBs (Fig. 5C,
top row) [0% (RB positive cells/transfected cells=0/287)]. The preva-
lence of RB formation was high to begin with for the poorly secreting
clones B and C at normal cell growth conditions (described already
above, B: 56%; C: 73%), but the BFA treatment further exacerbated the
occurrence of RB phenotypes (Fig. 5C, middle and bottom rows)
[B, 88.9% (240/270); C, 93.5% (87/93)]. Similarly, when the clones
in the second panel were examined under 24 h BFA treatment, high-
ly secreting clone 1 still did not develop discernible RBs, whereas
clones 2 and 3 increased RB forming prevalence (Suppl. 4B) as com-
pared to the conditions without BFA treatment. Evidence suggests
that biological episodes that perturb the efﬁciency of ER-to-Golgi
transport, such as temporal hypertonicity and osmotic stress [29],
Fig. 3. Steady state subcellular localization ofmodel human IgGs in transfectedHEK 293 cells. (A) HEK 293 cells were transfectedwith expression vectors encoding IgG clone A, B, or C. On
day-2 post transfection, suspension cultured cells were seeded onto poly-lysine coated glass coverslips and statically cultured for 24 h. On day-3, cells were ﬁxed with paraformaldehyde
and were co-stained with rabbit anti-human IgG (HC+LC) and mouse anti-calnexin, followed by appropriate secondary antibodies. The arrow in the bottom row points to the Russell
body in the transfected cell. The frequency of RB formation is mentioned in the text. (B) On day-5 post transfection, suspension cultured transfected cells were seeded onto poly-
lysine coated glass coverslips and statically cultured for 24 h. After paraformaldehyde ﬁxation on day-6 post transfection, cells were co-stained with rabbit anti-human IgG (HC+LC)
and mouse anti-GM130, followed by appropriate secondary antibodies.
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Fig. 4. Components of ER protein folding machinery are acutely induced upon transfec-
tion. On days-0, 2, 4, and 6 post transfection, suspension cultured cells were harvested
by centrifugation, then directly lysed and heat treated in 1× reducing SDS sample buff-
er. Prepared samples were resolved in SDS-PAGE. Western blotting was performed
using antibodies against designated proteins shown on the right side of each blot. To
calculate the fold increase of individual protein signals (mentioned in the text), the in-
tegrated signal intensity of designated protein bands was quantiﬁed (see Materials and
methods).
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secreting IgG clones.
To create situations where protein folding environments are
disrupted, we cultured the cells at 40 °C or in the presence of
thapsigargin. The heat shock treatment caused the appearance of
RB forming propensities from clone A at a low frequency [19.3% of
transfected cells, 63/327], whereas clone 1 remained largely resis-
tant to RB formation [4.4%, 5/114] (Fig. 6A). In contrast, thapsigargin
treatments revealed RB forming propensities from both clones A
and 1 at a higher frequency, 43% (87/202) and 32% (54/167), respec-
tively (Fig. 6B). These results illustrate that each IgG clone has a
unique inherent threshold to induce RB formation that can surface
differently under various cellular conditions. Depending on the
state of protein homeostasis in the ER, normally masked propensity
can surface precipitously and result in RB formation. The results
suggest that if the physicochemical properties of the cargo are iden-
tical, the differences in cellular context or capacity may inﬂuence
how efﬁciently the biosynthesis and secretion take place. This raised
the possibility that environmental stresses or viral infections that
deteriorate ER function can elevate the prevalence of RB formation
in some pathological settings in vivo.3.6. The LCs derived frompoorly secreting IgG clones are prone to aggregate
into RBs by themselves
To better understand the secretion level differences among IgGs,
we next analyzed subunit chains that comprise individual IgG clones.
By taking advantage of our recombinant systems, we expressed each
subunit chain separately to examine secretory differences and to
monitor the effects of single-chain overexpression on cell health. Al-
though it is generally accepted that LCs can escape from the ER and
be secreted by themselves as monomers and covalent dimers while
full-length HCs are unable to exit the ER efﬁciently [30–32], the quan-
tity of individual LC subunits secreted to the culture media showed
signiﬁcant clonal differences during the 24 h period between day-2
and day-3 post transfection, despite the designated polypeptides
being synthesized abundantly in the cells (Fig. 7A and Suppl. 6A).
Likewise, the amount of HC subunit released to the culturemedia varied
widely from clone to clone with some HCs being covalently aggregated
(Fig. 7A, lanes 8 and 12), although the amount of HC-only protein secret-
ed was much lower compared to that of LCs (Suppl. 7AB). Cumulative
secretory amount of individual subunit chains unequivocally indicated
that secretory propensity of individual subunit chains, particularly for
LC species, are markedly different from clone to clone (Suppl. 7AB). In
addition, the level of toxicity caused by individual subunit chain over-
expression to the cell host varied widely (Suppl. 7C). Because variable
domain sequences deﬁne distinct clones, the pronounced differences
among individual subunit chains during protein synthesis aremost like-
ly attributable to the variable domain sequence differences that com-
prise each clone.
To assess the contribution of each subunit chain to the RB forming
propensity of a whole IgG and to gain additional insights into the sig-
niﬁcant secretory differences among individual LC subunits, we next
examined the propensity of individual subunits to induce RB forma-
tion. When individually expressed, all three HCs of the ﬁrst panel in-
duced RBs (Fig. 7B) [A, 32.2% (69/214); B, 57.6% (137/251); C, 63.7%
(72/113)]. Although the frequency was slightly lower for clone A,
the results illustrate that all three HC clones had the propensity to ag-
gregate into RBs when their cognate LCs were missing. Importantly,
the cells expressing LC from high secreting clone A did not develop
any detectable RBs (Fig. 7C, top) [A, 0% (0/72)], although the LC
cargo accumulated in the Golgi area at steady state. In stark contrast,
the LCs from poorly secreting clones B and C induced RBs in nearly all
the cells expressing the polypeptides (Fig. 7C, middle and bottom
rows) [B, 92.4% (182/197); C, 82.9% (146/176)]. We obtained similar
results for the three IgG clones of the second panel (Suppl. 6B). Differ-
ences in RB-inducing propensity among individual LCs were therefore
a cause for the clonal variations in LC-only protein secretion. It has
been reported that LC subunits cooperate with ER resident molecular
chaperones to ensure the folding of HCs and Ig assembly [17,32].
However, our results advocate that not all LCs are equally equipped
with this ability. Depending on the level of intrinsic competence
(which is most likely to be embedded in the variable domain se-
quence), some LCs are able to prevent HCs from aggregating into
RBs, whereas other LCs are prone to aggregate into RBs by them-
selves, thereby rendering them ineffective as a chaperone and a struc-
tural component.
3.7. The efﬁciency of IgG assembly and secretion is dictated by the LC
subunit properties
Individual LC clone behavior is strikingly different when expressed
in the absence of HC subunits (e.g., RB induction, secretion, toxicity).
To examine the effect of LC competency differences on IgG assembly re-
actions, we investigated whether the LCs from highly secreting clones
would support high level IgG secretion when paired with non-cognate
HCs from poor-secreting clones, and vice versa. When the LC from
clone A was co-expressed with non-cognate HCs from clone B or C,
Fig. 5. The effect of pharmacological ER-to-Golgi transport block onRB formation. (A) HEK 293 cellswere transfectedwith expression vectors encoding human IgG clone A, B, or C. Onday-
2 post transfection, cells in suspension culture were harvested by 1000 g centrifugation and re-suspended in fresh cell culture media with or without 15 μg/ml Brefeldin A (BFA). Cells
were cultivated for another 24 h in suspension format before the cell culture media were collected on day-3, resolved by SDS-PAGE under reducing conditions, and analyzed byWestern
blotting to detect human IgG. A liquid volume corresponding to 5 μl of harvested cell culturemediumwas analyzed in each lane. The protein bands corresponding to the heavy chain (HC)
and the light chain (LC) are pointed out by arrowheads. The cell viabilities of clones A, B, and C expressing cells after 24 h BFA treatmentwere 88.5%, 89.8%, and 91.3%, respectively. The cell
viabilities of clones A, B, and C expressing cells after 24 h mock treatment were 89.3%, 89.1%, and 91.9%, respectively. (B) HEK 293 cells transfected to express IgG clone B develop readily
discernible RBs after 24 h BFA treatment. Arrows point to RBs. (C) On day-2 post transfection, transfectedHEK 293 cells were re-suspended in fresh cell culturemedia containing 15 μg/ml
BFA, then seeded onto poly-lysine coated glass coverslips and statically cultured for 24 h. On day-3, cells were ﬁxed with paraformaldehyde and were co-stained with FITC-conjugated
anti-lambda (top row) or anti-kappa chain (second and third rows) and Texas Red-conjugated anti-gamma chain antibodies. The RB forming frequency for each IgG clone after BFA treat-
ment is mentioned in the text.
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the original clone B or C (Fig. 8A, lanes 4 and 7). Likewise, when the LC
fromclone1was co-expressedwithHCs fromclone2 or 3, secretion titer
of the resulting new IgGs increased up to two orders of magnitude
higher than that of the original clone 2 or 3 (Suppl. 8A right, lanes 4
and 7). In contrast, when the LCs derived from poorly secreting clones
were co-expressed with the HCs from high secreting clones, the secre-
tion of IgGs was reduced drastically (~90% reduction, Fig. 8A, lanes
2–3; Suppl. 8A, lane 2) and in one case, modestly (~25% reduction,
Suppl. 8A, lane 3). Despite being full-length and structurally normal,
some LCs clearly lack the competence to facilitate efﬁcient HC folding
and IgG assembly; and these low competence LCs are sufﬁcient to signif-
icantly reduce the efﬁciency of IgG assembly and secretion.
To further establish correlations between secretion titer and RB for-
mation, we examined the RB inducing propensities of IgGs composed ofnon-cognate pairs of HC and LC. Consistent with the signiﬁcant improve-
ment in secretion titer (see above), when clone A's LC was co-expressed
with clone B's or C's HC, the prevalence of discernible RB formation was
signiﬁcantly reduced [A-LC+B-HC, 9.3% (20/214); A-LC+C-HC, 2.8%
(3/107)] (Fig. 8B). Likewise, when clone 1's LC was co-expressed with
clone 2's or 3's HC, RB induction was largely suppressed (Suppl. 8B).
The competency of the LC subunit therefore plays a key role in guiding
the overall efﬁciency of IgG assembly reactions.
3.8. The LC's high competence is required, but not sufﬁcient to ensure
high level IgG secretion
Our experiments provide evidence that the low competency of LCs
alone can negatively inﬂuence IgG assembly and secretion. However,
it is not yet clear whether the high competency of LCs is sufﬁcient to
Fig. 6. RB forming propensity of high-secreting clones can surface differently when the cells are cultured under stressful conditions. HEK 293 cells were transfected with expression
vectors encoding human IgG clone A or clone 1. (A) On day-2 post transfection, cells in suspension culture were re-suspended in fresh cell culture media and seeded onto poly-
lysine coated glass coverslips and statically cultured for 24 h in a 5% CO2 incubator at 40 °C before cells were ﬁxed on day-3. (B) On day-2 post transfection, cells were re-
suspended in fresh media containing 1 μM thapsigargin and plated onto poly-lysine coated glass coverslips and statically incubated for 24 h under normal growth conditions
prior to cell ﬁxation on day-3. After paraformaldehyde ﬁxation, cells were co-stained with FITC-conjugated anti-lambda chain and Texas Red-conjugated anti-gamma chain anti-
bodies. FITC and Texas Red ﬂuorescent images were merged (middle column). The RB forming frequency for each IgG clone under different cell culture conditions is mentioned
in the text.
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our original IgG panel, both of the high-secreting IgGs happen to
bear the λLC isotype (clones A and 1) while all the low-secreting
clones assume the κLC isotype. To evaluate the interplay of VH and
VL under a LC isotype matched setting, we identiﬁed one additional
human IgG1 (namely, clone Z, raised against a human growth factor)
from a random battery of IgG clones, based on its robust secretion
level (>200 mg/l), κLC isotype utilization, efﬁcient LC-only secretion,
lack of LC aggregation property, low toxicity, and low RB inducing
propensity (Suppl. 7 and 9). When the high-competent Z-LC was rep-
laced with four different isotype-matched low-competent κLCs, the
secretion titers of IgGs were all negatively affected as expected
(Fig. 9A). However, when the cognate LCs of six independent IgG
clones were replaced with Z-LC, the secretion titers of new IgGs
were mostly unchanged relative to the IgG titers expressed with cog-
nate LCs (Fig. 9B). Roughly 10-fold higher titer was achieved for the
two lowest-secreting IgG clones C and 2, but the absolute titers
were still one order of magnitude lower than typical high secreting
IgG clones. These results implicated that the high competence of LC
alone was not sufﬁcient to attain high level secretion. Instead, when
LCs are competent enough, the efﬁciency of IgG assembly appears
to be limited by the compatibility between VH and VL, which inﬂu-
ences the IgG assembly processes via a still elusive mechanism (see
Discussion). Collectively, our study demonstrates that the attributesthat govern the overall efﬁciency of subunit chain assembly reactions
during IgG biosynthesis are nested in the VH/VL pair sequence com-
position and combination.4. Discussion
4.1. Roles of variable domain sequences in IgG assembly and Russell body
formation
Current work revealed important differences in RB inducing pro-
pensity among structurally normal human IgG clones. Individual IgG
clones had unique thresholds to induce RB formation under normal
and abnormal cellular environments. The differential RB-inducing
predisposition unique to each IgG clone was corroborated by the in-
trinsic physicochemical properties encoded in the VH/VL sequence
combinations that deﬁne each single unique IgG clone. Our study ad-
ditionally showed that intricate interactions between the inherent
threshold genetically encoded in the molecule itself and the ﬂuctua-
tions of intracellular protein homeostasis determine whether IgG ex-
pressing cells would result in RB phenotypes under various cellular
conditions. Each IgG clone therefore has unique tolerance levels be-
fore inducing RB formation in response to temporary ﬂuctuations,
or potentially permanent changes, in cellular capacities.
Fig. 7. Differential roles of individual subunit chains in RB forming propensity. (A) HEK 293 cells were transfected with expression vectors encoding individual subunit chains of
human IgG clone A, B, or C. On day-2 post transfection, transfected cells were re-suspended in fresh media with or without 15 μg/ml BFA and maintained in suspension format
until day-3 when both cell culture media and cell pellets were harvested by 1000 g centrifugation. Western blotting samples for cell culture media and cell lysates were prepared
as before and probed using rabbit anti-human IgG (HC+LC). Top panel is the analysis for whole cell lysates under reducing conditions. Middle and bottom panels are the analyses
on cell culture media under reducing and non-reducing conditions, respectively. B-HC and C-HC were released as inter-molecularly disulﬁde-linked covalent aggregates (black-
boxed, bottom panel, lanes 8 and 12). (B–C) On day-2 post transfection, cells were withdrawn from shaker ﬂasks and plated onto poly-lysine coated glass coverslips and statically
cultured for 24 h using fresh normal cell growth media. On day-3 cells were ﬁxed with paraformaldehyde and were stained with FITC-conjugated anti-gamma, anti-lambda, or anti-
kappa chain antibody. A-HC and A-LC stand for the HC and the LC of clone A, respectively. The RB forming frequency for each subunit chain is mentioned in the text.
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clones, individual LC clones showed marked differences in their
(1) inherent propensity to be secreted by itself in the absence of ac-
companying HCs, (2) inclination to aggregate into RBs by them-
selves, and (3) intrinsic toxicity. Although the protective functions
of LCs in RB formation were suggested in transgenic mice expressing
truncated HCs lacking CH1 domain (i.e., in the absence of covalent
interaction between LCs and HCs [17]), our results illustrate that
not all the LC clones are equally capable of facilitating efﬁcient IgG
assembly by pairing up with full-length HC polypeptides. Unlike
the in vivo settings of transgenic mice where the entire repertoireof LC diversity is represented, in heterologous recombinant systems
it was evident that not all the LCs can confer such protective effects
on HC aggregation during biosynthesis. Because it is the variable do-
main sequence composition that deﬁnes individual LC clones, it
would be most consistent if we postulate that those differences are
rooted in the composition of variable domain sequences.
The HC/LC swapping experiments inadvertently highlighted that
the generation of variable domain sequence diversity and the cognate
VH/VL pair selection are not driven by the goal to maximize biosyn-
thetic efﬁciency during subunit chain assembly reactions. Why does
the cognate pairing of HC and LC not always result in the highest
Fig. 8. The competent LC from clone A can restore high level IgG secretion and prevent RB formation when paired with non-cognate HCs. (A) HEK 293 cells were transfected with
either a cognate or non-cognate pair of HC/LC constructs. Lanes 1–3 are for the LC from clone A, B, or C co-transfected with the HC from clone A. Likewise, lanes 4–6 are the three
different LCs paired with the HC from clone B, and lanes 7–9 are the three different LCs co-expressed with the HC from clone C. On day-6 post transfection both cell culture media
and cell pellets were harvested by 1000 g centrifugation. Western blotting samples for cell culture media and cell lysates were prepared as before and analyzed by using rabbit anti-
human IgG (HC+LC). Left panel is the analysis for whole cell lysates under reducing conditions. Middle and right panels are the analyses on cell culture media under reducing and
non-reducing conditions, respectively. In the right panel, determined IgG secretion titer in the harvested culture media is shown in each lane. (B) On day-2 post transfection, cells
transfected with non-cognate pairs of HC/LC, shown in lane 4 or lane 7, were withdrawn from shaker ﬂasks and plated onto poly-lysine coated glass coverslips using fresh cell cul-
ture media. After 24 h of static culture, cells were ﬁxed with paraformaldehyde and co-stained with FITC-conjugated anti-gamma chain antibody and Texas Red-conjugated anti-
lambda chain antibody. Top row, co-transfection with A-LC and B-HC. Bottom row, co-transfection with A-LC and C-HC. The RB forming frequency is mentioned in the text.
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pose that this could simply be an inevitable consequence of nature's
scaffold-based protein design strategy to accommodate maximum se-
quence diversity in one restricted structural conﬁguration. How can
variable domain sequences of HCs and LCs inﬂuence the IgG assembly
steps? Corcos et al. [17] described that the absence of selective pres-
sure for ﬁtting VH/VL combinations may retain adverse residues in
VH and may fail to provide counterbalancing residues to restore
charge or shape differences, thereby causing inefﬁciency of HC/LC as-
sembly and IgG folding. Our results support this model.
Chaperones are an integral part of immunoglobulin subunit chain
folding and assembly reactions [32–35]. What would be the roles of
speciﬁc ER resident chaperones such as BiP in RB formation? Surpris-
ingly, little is known when it comes to the direct roles of speciﬁc indi-
vidual chaperones in RB formation except that Ronzoni et al. reported
that PDI can inhibit while ERp44 promotes the formation of RBs when
tested in μ-HC with CH1 domain deletion mutation [9]. In homologous
experimental systems such as transgenic mice or hybridomas, the
roles of ER resident proteins that often bind to the CH1 domain are
difﬁcult to address directly because the CH1 domain of HCs is typically
missing due to somatic genetic deletion. In our experimental systems
using normal HC and LC subunits, a thapsigargin treatment that
broadly disrupts the functions of calcium-dependent ER resident pro-
teins markedly induced RB formation in the cells expressing structur-
ally normal human IgGs. This result articulates the indispensableroles of ER resident chaperones in preventing RB formation. When ec-
topically expressed individually or in combination, some selected ER
resident factors (e.g., BiP, PDI, cyclophilin B, pERp1, etc.) did not effec-
tively rescue the poor secretion phenotypes of our low-secreting IgG
clones, whereas co-expression of pleiotropic transcription factors
such as XBP1(S) or ATF6α(p50) reproducibly improved the secretion
of low-secreting IgGs roughly 3- to 5-fold (our unpublished data).
This may be a good illustration that enhancing the protein homeosta-
sis in a balanced fashion is more essential than simply elevating a se-
lect few key factors. The heterologous experimental system we use
conveniently allowed us to modulate the ratio of HC/LC protein levels
by simply changing the amount of expression vectors coding for HCs
or LCs during transfection. Having an excess amount of LC proteins
over HCs during IgG folding occasionally proved effective in increas-
ing IgG secretion level (our unpublished data). However, because
such beneﬁcial effects of excess LCs were not universally observed
for all IgG clones tested, it implicates again that VH and VL sequences
are inﬂuencing the assembly reaction steps via still elusive mecha-
nisms. It is worth noting that in our heterologous systems, the expres-
sion of RB-prone IgG tends to deteriorate cell health perhaps because
of the intrinsic toxicity of harboring insoluble aggregates in the ER.
However, in some established Mott cell hybridomas are viable for
long periods while maintaining RB phenotypes [4,36]. These apparent
discrepancies might be attributable to the beneﬁt of having native
cellular environments in hybridoma settings where presumably all
Fig. 9. Co-expression of a non-cognate HC/LC pair in a LC isotype matched condition. (A) HEK 293 cells were co-transfected with HC of clone Z (Z-HC) and ﬁve different κLCs from
clones Z, B, C, 2, and 3. On day-6 post transfection, both culture media and cell pellets were harvested and analyzed byWestern blotting using rabbit anti-human IgG (HC+LC). Left
panel is the analysis on cell culture media under non-reducing conditions. Right panel is the analysis for whole cell lysates under reducing conditions. In the left panel, determined
IgG titers are shown in each lane. (B) HEK 293 cells were co-transfected with Z-LC and seven different HCs from clones Z, A, B, C, 1, 2, and 3. On day-6 post transfection, the secretion
of titer was determined using the harvested culture media and it is shown at the base of individual bars. The dark gray bars represent IgG with cognate HC-LC pairing, whereas the
light gray bars show the titer of IgG where non-cognate Z-LC was co-expressed with individual HCs. The individual HCs used for transfection are shown below each bar.
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synthesis whereas the environments of 293 cells are foreign to Ig ex-
pression. Analysis on the original hybridoma clones that express our
model IgGs would be important to reconcile this critical difference
between homologous and heterologous systems.
The ﬁt clones were underpinned by genetically encoded favorable
properties that allowed these IgGs to fold and assemble efﬁciently
even when the initial cellular capacity was low. It was largely the capa-
bility of LCs (underpinned by the VL sequences) as well as the interplay
between the VH and VL sequence pair that governed high-level secre-
tion by facilitating efﬁcient IgG biosynthesis and by preventing assem-
bling subunits from aggregating into RBs. Although we argue that the
determinants ensuring efﬁcient IgG biosynthesis are embedded in the
variable-domain primary sequence, we have yet to decipher the exact
attributes, codes, or some kind of statistical feature within the VL se-
quence that constitute intrinsic high capacity as well as the compatibil-
ity between VH and VL sequences. BiP and LC are shown to cooperate
during immunoglobulin assembly [32]. Both in vitro in isolated domain
settings and in vivo, the interaction between the unstructured CH1 do-
main and the constant domain of LCs was shown to be essential for
the quaternary subunit assembly and secretion of IgG [34]. However,
these previous key studies mainly focused on the roles of constant do-
mains and therefore little is known as to how the composition of VH
and VL sequences inﬂuences the displacement of BiP from CH1 domain
[35] to facilitate the covalent assembly of LCs with CH1 domain. Future
investigation is needed to reveal the precise roles of variable domain se-
quences in IgG assembly reactions and the nature of intrinsic code that
makes some subunit chains more capable as assembly facilitators and
better structural components.We expect that uncovering themolecular
basis for what makes some subunits more competent than others
would lead to a better understanding of the Ig biosynthetic process
and fuel further interest in the biotechnology of antibody engineering.
4.2. Speculation on RB formation and humoral immune response in vivo
Although the potential roles of spontaneous mutations and somat-
ic hypermutations in RB formation were discussed in the past [10], it
became evident that structurally normal full-length IgG can induce
RBs under various cellular conditions in our heterologous systems. If
our observations in recombinant systems hold true, RB formation in
vivo can also be governed by the same set of simple principles weuncovered in this study, without taking mutations and primary se-
quence abnormalities into account. We propose that RB formations
in plasma cells of various B lymphoproliferative disorders and B cellma-
lignancies are caused as a result of interplay between the physicochem-
ical properties of each Ig clone and the protein folding and/or trafﬁcking
capacities of the cognate plasma cell that expresses each clone. We
speculate that, despite productive gene re-arrangement resulting in le-
gitimate VH and VL sequences and the initial “expressability” assess-
ment in maturing B cells, the properties of some Ig clones may not be
amenable to high-level overexpression. Therefore, evenprofessional se-
cretory cells might develop RBs and result in Mott cell phenotype. Po-
tential loss of cellular capacity due to cellular deterioration may also
increase the incidence of RB formation by allowing Igs to reach intrinsic
RB inducing thresholds precipitously.
Our study raised an interesting possibility that some normal Ig
clones in our natural immune systemwould inevitably have high pro-
pensities to induce RB formation during massive biosynthesis in plas-
ma cells. Such RB-prone Igs may not be secreted as efﬁciently as other
Ig clones. Some Ig clones may be circulating in our systemmore abun-
dantly than other clones at steady state. Even when the immune sys-
tem mounts acute responses to immunological episodes, the plasma
cells that express “favorable” clones may deploy their Igs much
more efﬁciently than the other plasma cells that express less favor-
able or unfavorable clones. In this sense, the RB formation in plasma
cells is a manifestation of ER storage disease phenotype where partic-
ular Ig clones are not secreted as efﬁciently as others, thereby limiting
their ability to launch protective humoral immune responses. It is at-
tractive to postulate that such Darwinian mechanisms would shape
and sometimes skew the repertoire of humoral immunity under dif-
ferent physiological or pathological conditions. Future investigation
may reveal instances where somatic hyper-mutations “ﬁx” RB pro-
pensities of parental IgGs to rescue their secretory levels.
4.3. Relevance of Russell body in therapeutic antibody discovery research
Recombinant human antibodies represent an expanding class of
promising human therapeutics [37,38]. Given the complexity of the
human antibody repertoire, it is not an easy task to identify the
unique antibody that can produce the desired therapeutic outcome
from a potential possibility of 108–1011 different clones [39–42].
Manufacturing of such antibodies at commercial scale would add
1656 J. Stoops et al. / Biochimica et Biophysica Acta 1823 (2012) 1643–1657another layer of challenge. Given the diversity of primary sequences
and the unique physicochemical properties of individual clones, one
can readily envision that not all the IgGs will have properties appro-
priate for large scale manufacturing and/or product formulation.
Our study illustrated that while some antibody clones were suitable
for overexpression, even in a transient burst expression where the
initial cellular folding capacity was rather limited, other clones were
apparently unsuitable. Therefore, in addition to identifying antibody
clones with potent biological functions, it is equally important to ac-
cess their ﬁtness for large scale manufacturing and/or formulation
at an early discovery stage.
RB detection assaysmay be used to screen a large pool of therapeutic
antibody candidates to differentiate the IgG clones that are suited for
cost-effective manufacturing from those that are not. Adaptation to an
image cytometry format in conjunction with an algorithm-based mor-
phometric data analysis [43] would accelerate the throughput to screen
a greater number of IgG clones. The cell-based RB detection assay may
also guide antibody engineering strategies to judge the effects and the
cost of primary sequence manipulation on overexpression ﬁtness. The
assay may also offer a rational tool when prioritizing synthetic anti-
bodies generated by using various display technologies in order to en-
sure that such antibodies are amenable to high-level expression in
mammalian cell hosts. Moreover, the assay could guide the selection
of subunit chains for the generation of more complex molecules, such
as bi-speciﬁc antibodies, to make sure that individual subunits are com-
patible with one another and have high competencies in assisting efﬁ-
cient quaternary complex formation.
Our study illustrated the risks of clone selection based on their bi-
ological functions alone. A RB detection assay would help mitigate the
risk of unknowingly selecting and advancing an IgG clone that later
turned out to be unsuitable for large-scale manufacturing or product
formulation. In fact, we previously demonstrated the potential value
of similar cell-based assay to preemptively detect a low solubility
IgG that crystallizes in vivo in the ER lumen and in vitro in a neutral
pH buffer [44]. We relied on the empirical determination of over-
expression ﬁtness by running the actual microscopy assays, but we
might eventually be able to predict the RB inducing propensity by
simply looking at explicit sequence information. Because the initial
steps of our model IgG clone selection were based on the antibody's
ability to confer desirable therapeutic effects by binding to the desig-
nated protein targets, our choice of model IgG clones was not biased a
priori to look for particular measurable physicochemical properties.
We suggest that an extensive survey on an array of measurable attri-
butes (e.g., a wide range of solubility, viscosity, isoelectric point, ther-
modynamic stability, etc.) may identify signature characteristics that
predispose certain IgG clones to induce RBs and/or result in poor IgG
secretion. For the success of an antibody therapeutic discovery pro-
gram, it is crucial to identify IgG clones that possess the desired bio-
logical functions and are endorsed by favorable physicochemical
properties; both of which in turn, are underpinned by the VH/VL se-
quence combinations.
Supplementary data to this article can be found online at http://
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